scholarly journals Clinical and prognostic value of hTERT mRNA expression in patients with non-small-cell lung cancer

2017 ◽  
Vol 64 (4) ◽  
pp. 641-646 ◽  
Author(s):  
Marzena Zalewska-Ziob ◽  
Katarzyna Dobija-Kubica ◽  
Krzysztof Biernacki ◽  
Brygida Adamek ◽  
Janusz Kasperczyk ◽  
...  
Lung Cancer ◽  
2001 ◽  
Vol 34 (2) ◽  
pp. 219-226 ◽  
Author(s):  
Hidenori Hara ◽  
Kazuya Yamashita ◽  
Jun Shinada ◽  
Hirokuni Yoshimura ◽  
Toru Kameya

2010 ◽  
Vol 2 ◽  
pp. BIC.S3383 ◽  
Author(s):  
Radostina Cherneva ◽  
Ognian Georgiev ◽  
Ivanka Dimova ◽  
Blaga Rukova ◽  
Danail Petrov ◽  
...  

Objective The early detection of NSCLC is of importance because it provides chances for better outcomes. The aim of the study was to explore the clinical utility of EGFR and hTERT mRNA expression as markers for diagnosis of NSCLC. Methods EGFR and hTERT mRNA were quantified by quantative reverse transcription real time polymerase chain reaction in plasma of 45 non-small cell lung cancer (NSCLC) and 40 chronic obstructive pulmonary disease (COPD) patients, selected by certain spirometric characteristics that made them at high risk of developing lung cancer in future. Results The gene expression level of each gene was calculated and given as a relative quantity–-RQ. EGFR gene expression was found in all lung cancer patients. The mean level of expression was RQ = 29.39. hTERT mRNA could be detected in 88% of patients. The mean expression ratio in them was RQ = 17.31. Only 50% of the high risk patients turned to be positive for EGFR. The level of their expression was RQ = 2.09. The plasma levels of hTERT could be detected in 17 (42.5%) patients of the high risk COPD group. Their mean level of expression was RQ = 1.02. A statistically significant difference in EGFR and hTERT mRNA expression could be observed between the two groups of patients–-p = 0.0001. Conclusion EGFR and hTERT mRNA are potential markers for lung cancer diagnosis, whose clinical importance should be replicated in a larger cohort of patients.


2021 ◽  
Vol 10 (3) ◽  
pp. 1216-1228
Author(s):  
Yuying Xiang ◽  
Feiyu Shan ◽  
Guan Feng ◽  
Kaibo Guo ◽  
Shanming Ruan ◽  
...  

2014 ◽  
Vol 9 (1) ◽  
pp. 449-453 ◽  
Author(s):  
LAURA BOLDRINI ◽  
MIRELLA GIORDANO ◽  
GRETA ALÌ ◽  
FRANCA MELFI ◽  
GAETANO ROMANO ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-11 ◽  
Author(s):  
Ying Liu ◽  
Jian Cui ◽  
Yun-Liang Tang ◽  
Liang Huang ◽  
Cong-Yang Zhou ◽  
...  

The S100 protein family is involved in cancer cell invasion and metastasis, but its prognostic value in non-small-cell lung cancer (NSCLC) has not been elucidated. In the present study we investigated the prognostic role of mRNA expression of each individual S100 in NSCLC patients through the Kaplan–Meier plotter (KM plotter) database. Expression of 14 members of the S100 family correlated with overall survival (OS) for all NSCLC patients; 18 members were associated with OS in adenocarcinoma, but none were associated with OS in squamous cell carcinoma. In particular, high mRNA expression level of S100B was associated with better OS in NSCLC patients. The prognostic value of S100 according to smoking status, pathological grades, clinical stages, and chemotherapeutic treatment of NSCLC was further assessed. Although the results should be further verified in clinical trials our findings provide new insights into the prognostic roles of S100 proteins in NSCLC and might promote development of S100-targeted inhibitors for the treatment of NSCLC.


2016 ◽  
Vol 50 (2) ◽  
Author(s):  
Eva Sodja ◽  
Matija Rijavec ◽  
Ana Koren ◽  
Aleksander Sadikov ◽  
Peter Korošec ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document